Pulsatile delivery of leptin receptor ligands
US5965521A · kind A · utility
7Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 1997 |
| Grant date | Oct 12, 1999 |
| Priority date | — |
| Expiry date | Feb 25, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/42
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a method for optimizing the administration of leptin receptor ligands to a mammal in need of such treatment. More specifically, this invention provides an improved method of delivering leptin receptor ligands to a mammal in need of such treatment comprising pulsatile or peak delivery of leptin receptor ligands to treat obesity and related conditions, including hyperglucocorticoidinemia, fertility or delayed puberty, and/or growth hormone deficiencies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.